Pelvic Pouch Complications

Welcome back to the deep dive. We are doing something a little different today. We are scrubbing in, putting on the loops and stepping right up to the operating table. Yeah, we are. We're calling this specific deep dive the colorectal surgery review. It's a definite shift in tone. We're moving past the general overview and we're aiming this one squarely at the practicing board-certified colon and rectal surgeon. Right. The assumption today is that you already know the basics. You know how to build a pouch. We aren't here to teach you how to fire a stapler. Exactly. We're here to talk about what happens when that pouch, you know, goes wrong. Our mission is to review the clinically relevant material that you need to know not just for your day-to-day practice, but to stay sharp. Just to be sharp on the changes in the field, yeah. And the board exam I knew, you should have those little details that always seem to pop up on the in-service exams. Those questions that are designed to see if you're really paying attention. And of course the complex decision-making trees we all face. And to guide us through this this mine field really, we are doing a comprehensive deep dive into the chapter complications of the pelvic patch. The one by Geneage Ashburn and David W. Deats. That's the one from the ASCRS textbook of colon and rectal surgery, which is, I mean, it's essentially the Bible for our subspecialty. It's the heavy artillery. And honestly, the stakes couldn't be higher, could they? We all know the Ileoenal pouch analenastomosis. The IPAA is the gold standard for ulcerative colitis and FAP. It is. It restores domafree living. It's a massive, massive quality of life win for these patients. When it works. When it works, that's the key. But the reality is failure happens. It's not common. But when it does occur, it is devastating. It really is. It affects everything. Body image, sexual function, their long term health. The focus of Ashburn and Deats here isn't the happy path where the patient is high-fiving you in the clinic. It's the salvage path. We have a tremendous amount of ground to cover. We're going to unpack what we're calling the big five concepts from this text. We're talking about pelvic sepsis as the absolute arch nemesis of the pouch. That's number one. The number one cause of patch loss without a doubt. We also really need to dissect the Crohn's misdiagnosis. Oh, that's a huge one. It's a massive pitfall that leads to perfectly savable pouches being excised. Then we've got the structure and assessment algorithm, the nuance of differentiating mechanical versus inflammatory failure, and a concept I really loved. The thoughtful aliostomy. It's a brilliant way of framing diversion, isn't it? But love not get ahead of ourselves. Let's start where the surgeon always starts with the patient. Okay. Section one. The structure and assessment of the failing pouch. The clinical scenario is one that every single one of us has seen. A patient walks into your clinic, maybe five, maybe 10 years after their index surgery. And they are miserable. Utterly miserable. Frequency, urgency, pain, maybe leakage, they're desperate. And the knee jerk reaction from, say, the referring provider, or even from us if we're rushing, is almost always it's puketis or, oh, it must be Crohn's disease. It's the easy button, right? Prescribes in Cipro, maybe start a biologic. Exactly. And Ashburn and Dietz argue that this is where the first potentially fatal mistake happens. You cannot treat a mechanical problem with antibiotics. And you certainly shouldn't be treating a septic problem with immunosuppression until you know exactly what you're dealing with. Precisely. So they propose this standardized assessment. And what's interesting is it doesn't start with the physical exam. It starts with the history. And specifically, the operative note from the original case. You have to become a detective. You absolutely have to. You need to pull that old op note. You're looking for the narrative of the original crime scene, so to speak. What specifically are we hunting for in that document? What are the red flags? You're looking for technical missteps or, you know, struggles. Did the surgeon mention tension? Do they have to make relaxing incisions in the mess and Terry? Was there any note of ischemia or dusky bowel? Anything about a difficult reach into the pelvis? That's a huge one. If that pouch was under tension from day one, that completely informs your differential diagnosis today years later. And there's a specific clinical pearl here about medications at the time of the original surgery. This feels like a classic board exam question. It absolutely is. You need to look at the immunosuppression load at the time of pouch creation. If the patient was on high dose steroids or biologics, when that anastomosis was made. That's a problem. It significantly increases the risk of what we call occult sinus tracks. Occult meaning hidden basically. Yes. These tracks can be totally silent for years. The pouch kind of heals over them or they just simmer quietly in the background. Then years later, they present with symptoms that perfectly mimic poochitis. And if you don't know the backstory. If you don't know the patient was on 60 milligrams of prednisone back in 2015, you might completely miss the fact that this is actually a chronic, small-during sinus from the original surgery, not new inflammation. That is a fascinating and critical connection. So history gives you the context. Once we have that, we move to the diagnostic triad the authors recommend. And this triad is non-negotiable. It's a doscopy examination under anesthesia, the EUA and imaging. Okay, let's break these down. Because the text is very specific about how these should be done. And doscopy seems obvious. But the authors argue it's often done with what tunnel vision. That's a great way to put it. Most endoscopists just look at the mucosa. They see red and they say, okay, it's red poochitis. And that's not enough. That is grossly insufficient. A standardized pochoscopy for a failing pouch requires a full structural assessment. You have to inspect the rectal cuff for cifitis. You have to look at the actual geometry of the pouch body. And the afferent limb? Crucially, you must intubate the afferent limb, the bowel leading into the pouch. And you aren't just looking for inflammation, you're looking for structural clues, twists, strictures or angulations. So if the afferent limb is dilated, you might assume it's backwash dilated as from inflammation. But if you look closer, it could be a distal obstruction causing that dilation. The scope is a structural tool here, not just a mucosa one. Then comes the EUA. Why is this so critical if we just had a camera in there? Because the scope sees the lumen, the finger feels the thethology. The EUA is the single most sensitive tool for identifying fishtal A and abscesses that you simply cannot see on endoscopy. Because they're buried. They're buried in the tissue folds. You're feeling for compliance. Is the pouch soft and distensible? Or is it woody and fixed to the sacrum? You assess the anal synchroid tone. And crucially, you're feeling for a pre-socral collection or a boggy area that just screams chronic sepsis. And finally, imaging to round out the triad. Contrast animals and pelvic MRI. You're looking to rule out an asthmotic complications leaks or pre-sicral collections that are sitting completely outside the lumen. The MRI gives you that soft tissue road map that the scope just can't see. Now there's a specific recommendation here about who should be in the room for these procedures. This touches on the multidisciplinary approach. The authors see huge value. And I completely agree in having the gastroenterologist and the surgeon in the OR together during the EUA or parachoscopy. Which sounds great in theory, but I can imagine it's a logistical nightmare to schedule. It is difficult, but for a complex failing pouch, it's worth every bit of effort. It aligns the diagnosis in real time. What's an example of that? Okay, so the GI specialist looks at the screen and sees redness and says that's inflammation. Let's increase the biologics. The surgeon is looking at the exact same redness, but feels the tension on the exam and says, no, that's ischemia because the messenteria is tight. We need to release it. That's the aha moment right there. It is. If you're not in the room together, that patient gets labeled with IBD when they actually have a twisted messenteria. Precisely. And that misdiagnosis sends them down a path of medical therapy that will never, ever fix the underlying mechanical problem. Let's assume we've done the assessment. The patient is suffering, they're malnourished, maybe they're septic, constantly in the bathroom. This leads us right into section two, the thoughtful iliostomy. I really appreciate this terminology, thoughtful. It elevates the procedure from a sign of defeat to a genuine strategy. Because often, surgeons and especially patients view going back to an ostomy as the end of the line a failure. Right, but Ashburon indeed frame it completely differently. It's a diagnostic and therapeutic tool. A strategic pause. The strategic pose, that's perfect. You divert the fecal stream for a couple of key reasons. First, you cool down the pelvis. If there's severe mucosal inflammation, just stopping the constant irritation allows that inflammation to subside. And that lets you see the truth. And let's you see the true state of the tissue. You can finally answer the question, is it really crowns or was it just severely irritated by stool stasis? And the second reason is just quality of life. It's palliation. If a patient has severe perennial excoriation, if they have urgency 20 times a day and they can't sleep, an ostomy gives them their life back immediately. They can actually get some nutrition reserved back. They can sleep through the night. Yes. And it's also a trial run, isn't it? A trial run exactly. Some patients are terrified of losing the pouch because they fear the bag more than anything. A temporary diversion lets them test drive it. They might realize, wait a minute, I feel amazing. I can go out to dinner. I don't need this dysfunctional pouch. It clarifies their priorities before you commit to a massive life-altering, reduced surgery. It really does. Now let's get into the board exam minutiae here. There is a very specific technical rule mentioned regarding the creation of this thoughtful, Iliostomy. The 15 centimeter rule. Let's unpack this. Why 15 centimeters? When you create this diverting loop elios to me. It must be placed at least 15 centimeters proximal to the pouch inlet. And this is strictly about future proofing. You're thinking about the next surgery before you even finish this one. Always, you have to. If this pouch ultimately fails and needs to be excised, or if you need to do a major revision, you're going to need a segment of healthy, well-vascularized bowel to create a new pouch anal enastamosus. And if you put the stoma right at the pouch inlet, you burn that bridge. You damage the vessels and you use up the bowel length you might desperately need later on. So you leave yourself a 15 centimeter runway? Exactly. You preserve the vascular arcade. It's a small technical detail that can save you from massive headaches five years down the road. And while you're in the abdomen creating this stoma, the text advises against a pop-up approach, right? Oh, never just make an incision, pull a bluepebowl, and leave. This is a golden diagnostic opportunity. You should be performing a laparoscopy at the very least. Explore the abdomen. Yes, you can find mispethology, mesenteric twists, adhesions, internal hernias. You have to treat the diversion surgery as a fact-finding mission. Okay, moving on to section three, we're getting into the real mechanics of failure, structural complications of the affront limb and the pouch body. This is an area where our understanding has evolved significantly in the last decade, I'd say. We used to use the term affront limb syndrome, or ALS, pretty loosely. And it usually just meant a mechanical kink. But the new understanding is that ALS represents a pretty diverse group of findings. It can include fibro-stotic strictures, acute angulation, and even volvulus. And this brings us right back to that cron's trap we teased in the intro. This is critical for the boards and for practice. ALS findings, so we're talking fibrosis, ulceration, and inflammation in the pre-pouch alium, often look exactly like cron's disease on endoscopy. So you put the scope in, you see an ulcerated narrowed segment of valve just upstream from the pouch. Your brain immediately says, "Classic terminal Ileatus." But so often it is not. It's mechanical trauma. It's a twist causing ischemia or chronic tension causing ulceration. And if you misdiagnose this as cron's, you might condemn a patient to a lifetime of biologics or, worse, excise a pouch that could have been saved with a simple mechanical fix. That is a huge distinction to make. A twist versus an autoimmune disease. What are the common mechanical causes here? It almost always traces back to the index surgery. The 180 degree, or believe it or not, a full 360 degree mesenteric rotation that was just missed at the time. Or entrapment. Or entrapment of the affront limb under its own mesenteri. So how do we manage this? Well, if it's a simple short-stricture, you can try endoscopic balloon dilation. But for refractory cases, or if you're imaging really suggest a twist, you have to go to surgery. Resection of the structure, a stricture plastic, or just a simple derotation in pexy. Moving down from the affront limb to the pouch body itself, the author's discuss scaffolding failure. I love that imagery. It explains the physics of the failure so well. Think about how a J-pouch is constructed. The posterior wall is made from the mesenteric side of the bowel. It's tethered by the blood supply. It's relatively rigid. But the anterior wall. But the anterior wall is the antimes and terric side. It's free. It's floppier. And the time with years of filling and emptying, that floppy wall can cause trouble. It sure can. It can prolapse internally. It folds in on itself and blocks the outlet like a ball valve. Or it can become tethered to the pre-sacral fascia, which changes the whole angle of defecation. And the symptoms would be what? Abstructive symptoms. The patient feels the urge to go. They know the pouches fall. But they strain and strain and nothing comes out. It's a functional outlet obstruction. And the things for this flaky wall. It's a pouch pexy. Essentially have to hitch that floppy anterior wall up. Sometimes you have to use mesh or a biologic matrix to secure it to the sacral promontory or the abdominal wall to restore that scaffolding. The authors do note the data on mesh is limited, but the mechanical concept is sound. There's one more structural issue mentioned here. The tip of J-leak. Ah, yes. The tip of the J is the blind end of the pouch. And physiologically, it's the furthest point from the blood supply. It's the watershed area of the pouch. Which means it's prone to ischemia. Uniquely so. It's prone to ischemic injury or staple-line dehesins. And if that tip leaks, it very rarely heals with just antibiotics. Because the tissue is already ischemic. You've got a hole in dead tissue. So it needs surgery. It usually requires surgical revision to resect that ischemic tip and re-close it with healthy tissue. Okay. Let's pivot to the biggest adversary we face. Section 4. Cepsis and anestomotic leaks. This is the heavyweight champion of pouch failure. No question. The statistics are really sobering. They are. Povexepsis occurs up to 25% of patients in some series. It is the number one cause of pouch loss. If a patient develops sepsis, they have a 30% failure rate right off the bat. It determines the long-term function of that pouch more than any other single factor. We need a clear decision tree here. This is the 2.0 AM scenario. A pouch patient presents with sepsis. They have a fever, pain, elevated white count. What do we do? The algorithm depends entirely on two factors. The location of the abscess and the dynamic stability of the patient. Okay. Let's run the scenarios. Scenario A. An upper pelvic or abdominal abscess. It is accessible from the belly wall. CT or ultrasound guided percutaneous drainage. Do not open them if you can possibly avoid it. You want to control the source of that alapurotomy which would just introduce more morbidity and adhesions. Scenario B. A lower pelvic abscess. Deep in the pelvis. Between the pouch and the sacrum. You can't reach that percutaneously without going through the bladder or the pouch itself, which you don't want to do. So, you manage this with trans-anel drainage via an EUA. You find the defect in the anastomosis and you drain it internally. And the text specifically calls for a mushroom catheter. Why that specific device? This is a key technical detail for the boards. A malachot or mushroom catheter is self-retaining. It has those wings that flare out and keep it in the cavity. Unlike a pigtail catheter which can easily clog with stool, the mushroom allows for continuous drainage of the cavity into the pouch. So you're essentially converting an undrained abscess into a controlled fistula. That's exactly what you're doing. It's a critical management step. And then there's Scenario C, the nightmare, hemodynamic instability or generalized paratonitis. This is the worst-case scenario. You have no choice. You have to take them for a wash out. And the authors provide a grim statistic here. If you have to take a pouch patient for an acute wash out, the patch decision rate is over 40%. Wow. That's a number worth remembering when you're counseling families about how serious the situation is. Now, what about the chronic complications of sepsis, the sinus tract? This is surprisingly common. The incidence is between 2.8% and 8%. And it usually hides on the posterior aspect of the anastomosis down in the pre-sacral space. Let's say you find a sinus tract on a routine poachogram before you plan to close a patient's eliosdomy. The patient feels fine. They're totally asymptomatic. What do you do? This is a classic trick question on the boards. An asymptomatic sinus found before closure. The answer is, do nothing to the sinus itself. Nothing. Do not go digging. Do not unroof it. But you must delay the eliosdomy closure given another 3-6 months. Most of these will either heal or become stable on their own. If you intervene aggressively on an asymptomatic sinus, you often make it worse or create a much larger defect. If it is symptomatic, the patient has pain, discharge, recurrent abscesses. Then you have to act. You can do a de-roofing and endoscopic needle-knife sinusotomy, which is a very specialized skill involving cutting the bridge of tissue between the sinus and the pouch limb. Or you can place chronic seat-ins to keep it draining and prevent abscess re-accumulation. Here is a nuanced point the authors make that I found critical differentiating an anestomotic sinus from Crohn's Fistualizing Disease. How on earth do you tell the difference? It really comes down to tissue quality. This is the tactile art of surgery that you learn over time. In an anastomotic sinus, which is usually just a chronic leak, the surrounding tissue is often surprisingly supple. The fibrosis is localized strictly to the tract itself. And in Crohn's? In Crohn's, the tissue is woody, it's indirated, it's fibrodech, the inflammation is transmural and it's widespread. So supple versus woody is the clue? Correct. And getting that distinction wrong is so dangerous. If you label a chronic leak as Crohn's, you might put the patient on biologics. Biologics impede healing. So you're actively preventing that sinus from closing. And the other way around. Conversely, if you operate on active Crohn's thinking it's a simple sinus, you will cause a disaster and you will almost certainly lose the pouch. Let's move down to the outlet. Section 5. Effort limb complication. We're talking about the way out. So primarily, strictures at the anastomosis. Is there a difference in stricture rates between stapled and hand-zone anastomosis? You know, surprisingly no. The text says the incidence is pretty similar, up to 17% in both groups. But the type of stricture matters significantly for management. A huge difference. A stricture in a stapled anastomosis that was simply diverted for a while is often soft and web-like. It's a diaffinous ring. You can often just break it with your finger or dilated easily with higard dilators in the clinic. And the other type? The structure that results from sepsis, a leak, or ischemia is vibrotic. It's hard, dense, scar tissue. These do not respond well to simple dilation, they just recoil. They often require a much bigger operation like a pouch advancement where you disconnect and pull healthy pouch down or a complete revision of the anastomosis. Then we have the long cuff. This sounds like a technical error at the index surgery. It usually is. The whole goal in UC is to remove the disease nucusa. If you leave an elongated rectal cuff, say, greater than two centimeters. You are leaving a reservoir of diseased buucosa. This causes chronic cuffitis. But it's also a mechanical problem. It's also a mechanical problem. That cuff doesn't descend like the pouch does. It acts like a stiff narrow pipe at the end of a balloon. It's a functional obstruction. There's also mention of the elongated S-pouch outlet. Yeah, the S-pouch is less common now, largely because of this very complication. If that outlet spout the effrent limb of the S is made too long, it kinks when the pouch fills up. The patient can't empty spontaneously. So they have to catheterize themselves? They have to catheterize themselves to poop. It's a classic mechanical failure of that specific design. And finally, the mesorectal collar. This was a new concept for me, or at least a new way of visualizing it. It's an interesting debate in the field, right? It's about the protective me. Some surgeons preserve the mesorectum, the fat surrounding the rectum during the dissection, thinking it protects nerves or helps to fill the dead space. But Ashburn and Deets wave a big red flag here. They do. They point out that this retained mesorectum can act as a constructive band, a collar around the distal pouch or the anastomosis. As the pouch dilates over time, that collar stays tight. It essentially strangles the outlet. Exactly. And the solution there is a major, major operation. You have to go back in, transabdomally, perform a completion mesorectal excision and do a redo anastomosis. It's a massive undertaking to fix a decision that was made just to fill space. Okay, let's shift gears to section six, inflammatory complications. This is the bread and butter of daily pouch dysfunction, isn't it? It is. We're talking about poochitis, the most common long-term complication. Depending on the series you read, up to 50% of patients will get it at some point in their life. But the key takeaway from this chapter is that poochitis is not one single disease. The authors break it down into three distinct phenotypes. This is so crucial for management because the treatments are completely different. Completely different. First, you have the classic phenotype. This is likely due to dysbiosis and imbalance of bacteria in the pouch. It responds beautifully to a two-week course of superflocal and flageal. Simple. Then you have the immune-mediated phenotype. This is often seen in patients who have extra intestinal manifestations like PSC, primary sclerosintral and gytus, or other autoimmune issues. It's much more stubborn. It acts a lot more like IBD. And the third one, this is the one that really caught my eye because it changes the treatment paradigm completely. Eschemia-associated poochitis. This is the board-review profile right here. Listen closely to this one. The patient is typically no beast male. They have significant visceral adiposity, a thick, heavy messantary, and what do you see on the scope? Asymmetric inflammation. That is the keyword. One wall of the pouch is inflamed and angry, and the other side is pristine, or the inflammation is just along the staple line. Why asymmetric? Because it's not a bacterial fluid problem that affects everything. It's a tension problem. The heavy fat is pulling on a messantary, causing low-grade ischemia to that specific segment of the pouch wall. So if you give this person antibiotics. It won't work. It is not a bacterial problem. It is a blood flow problem. The treatment is weight loss. You have to relieve the mechanical tension on the messantary. That is a brilliant distinction. Stop throwing sippero at the obese male with asymmetric inflammation on his puchoscopy. Council him on weight loss. Exactly. Recognizing that phenotype saves the patient months of useless antibiotic therapy and frustration. What about cifetus? Cifetus is simply ulcerative colitis coming back in the small amount of retained rectal cuff. The symptoms can mimic Puchitis urgency, bleeding, frequency, but the treatment is different. Because it's UC. Right. It's UC. Systemic antibiotics don't work well here. You need topical therapy. Topical mesellamine, five ASA suppositories or steroid foams. You treat it exactly like you would treat proctitis in a patient who still has their rectum. Now we have to talk about the bogeyman, Crohn's disease of the pouch. The authors have a great line for this. They call it and over-subscribed diagnosis of exclusion. Meaning we diagnose it far too often. Way too often. We see inflammation, we don't understand, or a fistula we can't explain. And the easy way out is to say it must be Crohn's. And that label carries such heavy baggage. But let's say it is Crohn's. The pathology confirms granulomas or there's clear upstring disease. Does that automatically mean the pouch has to come out? No. That is the old dogma. And it's wrong. The reality check here and it's a big one is that a diagnosis of Crohn's does not automatically equal pouch excision. What are the pouch retention rates? They're reported at 57% in the text. Some more than half of these patients keep your pouch and have decent function long term. That's actually very encouraging. It is. However, there is one major risk factor. If the patient had a fistula at the time of their original diagnosis or significant perianal disease, that is an independent predictor of failure. Those patients really struggle. But for the others, we manage it with combined therapy. Exactly. It's medical and surgical. You use seat-ins to control the sepsis and drain the fistulas and you use aggressive biologics to control the mucosal inflammation. It's a battle for sure, but it's often a winimal one. Let's move to section seven. Functional disorders and neoplasia. This is the tough group. Sometimes the pouch looks perfect on the scope. The MRI is clean, but the patient is still absolutely miserable. Enter IPS, irritable pouch syndrome. It's the IBS of the pouch world. It is purely a diagnosis of exclusion. There's no inflammation, no infection, no mechanical issue. It's just visceral hypersensitivity. The nerves are firing way too much. Then do we treat that? It's tough. You try antispasmodics, anticholinergic to slow things down, but surprisingly cognitive behavioral therapy, CBT and low dose antidepressants are actually quite effective here. You have to retrain that brain gut access. And dysinergic defecation. The great paradox. The patient pushes to poop, but their pubert callus muscle contracts instead of relaxing. It slams the door shut. They're literally fighting their own pelvic floor. How do you diagnose that? High-resolution intereclemonometry and the balloon expulsion test. You can actually prove that they can't push the balloon out properly. And the treatment. Biofeedback. It's not a surgical problem. You have to send them to a specialized physical therapist to teach them how to coordinate the muscles to poop again. Surgery only makes this worse. Let's touch on neoplasia quickly. The risk of cancer in the pouch. The good news is it is rare. Very rare. The text notes less than 50 cases have been reported in the entire literature at the time of publication. But where does it hide if it does develop? Almost always in ATZ, the anal transition zone or the recal cuff. That is where the native eucosa is. The tissue that was at risk in the first place. And the main risk factor. It's prior dysplasia or cancer. If they had cancer in their colon that led to them getting the pouch, they're at a higher risk for developing cancer in the pouch down the line. Surveillance is absolutely key for that specific group. Okay. We're coming to the end of the road here. Section 8. The end game. Salivage versus excision. This is the ultimate decision matrix. Yeah. And frankly, there are no randomized trials to guide us here. Every decision is highly, highly individualized. Let's talk about excision first, taking the pouch out. It is not a simple fix. Patients and sometimes even surgeons think, just take it out, give me the permanent bag and all my problems will be solved. But the morbidity is incredibly high. A 57% short term complication rate. That is massive. You are dissecting into scarred, hostile pelvis that's been operated on multiple times. And what's the Achilles heel of pouch excision? The perineal wound. You were removing the anus, this fincter's the pouch itself. You're leaving a large dead space deep in the pelvis with no pelvic floor to support it. And it just doesn't heal well. A 40% non-healing rate at six months. Patients can end up with a chronic draining perineal sinus that is actually worse than the dysfunctional pouch was. It is a nightmare to manage. So excision is not a free pass by any means. What about redo pouch surgery, saving the anatomy? This is where the Renzi series from the Cleveland Clinic is really the gold standard data. They looked at over 500 patients who underwent redo pouch surgery. What are the numbers like? They're amazing. 83% functional at follow-up. The five-year survival of the new pouch is 90%. Those are incredible odds for a patient who has been told they failed. They are. And patient satisfaction is over 90%. They would do it all again. So who is the best candidate for a redo? The patient with a technical failure, the twisted pouch, the long cuff, the septic leak that can be definitively fixed. If the plumbing is wrong, we can often fix the plumbing. And the worst candidate? Severe ac te Crohn's disease or very poor sphincter function. Redu surgery in the face of Crohn's has much much lower success rates. If the tissue itself is bad, new plumbing won't fix the problem. Finally, for the patient who wants continents but simply cannot have a pelvic pouch, maybe their sphincters are shot or the pelvis is frozen solid, the continent eliaustomy, also known as the cock pouch. The cock pouch is this fascinating historical operation that still has a very important, very specific niche role. It's an intra-abdominal reservoir made of small bowel, with a nipple valve made by insincepting the bowel into the pouch. And the patient puts a catheter into a flush stoma on their belly to empty it. So no bag. No bag and a very high quality of life for the right, highly motivated patient. But there's a catch, isn't there? There is the nipple valve. It relies on that inter-susception staying put. But the high pressure in the pouch tends to push the valve inside out over time. We call it valve slippage. The re-operation rates are high. You have to be willing to undergo maintenance surgery to keep the valve functional. But for the patient who absolutely refuses an external appliance, it's a viable option. It is. And for those select patients, satisfaction is very high. They're willing to undergo the revisions. to stay bag free. Okay, that was a marathon review. Let's bring it all home. What are the key takeaways from Ashburn and Deets for the boards and for the wards? Okay. Number one, don't rush to a Crohn's diagnosis. It's probably mechanical or septic. Keep looking. Number two, the exam under anesthesia is your single best diagnostic tool. Use your finger, feel that's issue. Number three, manage sepsis aggressively. Use the mushroom catheter divert early. It determines the entire long term function of the pouch. And four, reduce surgery is real and it works. Don't write off a failed pouch as a permanent alioscomy without a real fight. And I'll leave you with a final thought from the text that really stuck with me. The authors mentioned the remarkable uniqueness of every failure. That's the art of medicine, isn't it? Yeah. Cookie cutter algorithms fail the complex pouch patient. You have to look at the specific anatomy, the specific history, and the specific goals of that human being sitting in front of you. That is why we study the minutiae. Because in those details, the pouch is saved or lost. Thank you for scrubbing in with us today on this colorectal surgery review. It was a pleasure. Keep questioning the diagnosis. See you on the next deep dive.